PoreWise

One finding · In vitro study · 2016

Study title

Human skin penetration of hyaluronic acid of different molecular weights as probed by Raman spectroscopy

Kind of evidence
In vitro study 2016 · Excised human skin sections · PMID 25877232
Measured outcome
How deep it gets
Year
2016
Who was studied
Excised human skin sections
Sample size
Measured outcome
Hyaluronic acid of 20-300 kDa crossed the stratum corneum in excised human skin, while hyaluronic acid of 1000-1400 kDa remained in the stratum corneum.
Certainty
Moderate
Who was measured
Excised human skin with intact stratum corneum, measured by Raman micro-imaging after topical application.
Study limits
One laboratory's imaging study. Three molecular-weight grades were tested. "remains above" describes intact stratum corneum in this ex vivo setup.

Where it comes from

PMID 25877232

Ingredients it was measured on

Other findings on the same ingredient or concern

  1. Skin effect
    Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment

    All five 0.1% hyaluronic acid creams tested, from 50 kDa to 2000 kDa, raised skin hydration and overall elasticity above the vehicle cream applied to the other eye at 60 days.

    Human trial · 2011 · 76 people · Women aged 30-60 with periocular wrinkles · 0.1% hyaluronic acid creams applied twice daily for 60 days to the eye area of women aged 30-60 with periocular wrinkles. · Sixty days, and the vehicle sat on the fellow eye. Hydration and elasticity were read by instruments. The volunteers were women aged 30-60 with eye-area wrinkles.

    PMID 22052267

  2. Skin effect
    Hyaluronic Acid (CeraVe ingredient page)

    Hyaluronic acid and its salt bind water at the skin surface, giving a plumper look immediately after application.

    Brand claim · Leave-on hydrating products. · The effect is largely surface and temporary. In dry air a humectant. · Finding · Sodium hyaluronate · Hydrolyzed hyaluronic acid

  3. How deep it gets
    Fifty-kDa hyaluronic acid upregulates some epidermal genes without changing TNF-α expression in reconstituted epidermis

    In reconstituted human epidermis, hyaluronic acid of about 50 kDa penetrated better than the larger grades and increased expression of genes and proteins involved in tight-junction formation and keratinocyte cohesion; its TNF-α expression stayed close from the 20 kDa grade.

    In vitro study · 2011 · Reconstituted human epidermis (in vitro) · Reconstituted human epidermis incubated with hyaluronic acid of 20, 50, 130, 300, 800 and 1500 kDa. · The material tested is a defined ~50 kDa grade.

    PMID 21412035

  4. Skin effect
    Efficacy of a New Topical Nano-hyaluronic Acid in Humans

    Eight weeks of a low-molecular-weight "nano" hyaluronic acid lotion, serum and cream reduced measured periorbital wrinkle depth by up to 40% and raised corneometer hydration by up to 96%.

    Human trial · 2014 · 33 people · Women with a mean age of 45.2 years · A three-step regimen (lotion, serum, cream) built on a low-molecular-weight hyaluronic acid, used for eight weeks on women with a mean age of 45.2. · The percentages are within-group changes. 33 participants in one centre, and the material is described as "nano" hyaluronic acid.

    PMID 24688623

  5. Skin effect
    Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment

    Periocular wrinkle depth improved against vehicle with the 50 kDa and 130 kDa hyaluronic acid creams; after 60 days the 300, 800 and 2000 kDa creams matched vehicle on measured roughness.

    Human trial · 2011 · 76 people · Women aged 30-60 with periocular wrinkles · Replica-based roughness measurement (mean roughness Ra, maximum roughness Rz) of periocular wrinkles, with 0.1% creams applied twice daily for 60 days. · Wrinkle depth was an instrumental secondary measure on women who already had periocular lines. The trial stopped at 60 days. The five creams differed in molecular weight, shared a base formula.

    PMID 22052267